Breast imaging illustration
Understanding Risk

BRCA1 Gene Mutation

What a BRCA1 mutation means for your breast cancer risk

Upload Report
Quick Answer: BRCA1 is a gene that helps repair damaged DNA and protects cells from growing out of control. A harmful BRCA1 mutation significantly raises lifetime risk for breast and ovarian cancer. It does not mean you currently have cancer - but it does mean your screening plan should change, and your family members may also need testing.
🩺

A Note from Our Radiologist

In breast imaging, BRCA1 status is one of the most important pieces of information I use when planning a patient's screening. Women with a BRCA1 mutation qualify for annual breast MRI in addition to mammography - often starting as early as age 25. If you have a known mutation or a strong family history and have not yet had a formal risk assessment, that conversation with your doctor should happen soon.

What Is the BRCA1 Gene?

BRCA1 stands for Breast Cancer gene 1. It is a tumor suppressor gene - meaning its normal job is to produce a protein that helps repair damaged DNA and prevents cells from growing and dividing too rapidly or in an uncontrolled way.

Everyone has two copies of the BRCA1 gene - one inherited from each parent. When both copies are working correctly, the body can repair DNA errors efficiently. When one copy carries a harmful mutation, that repair mechanism is weakened, and the risk of certain cancers - particularly breast and ovarian cancer - rises substantially.

BRCA1 mutations are found in people of all backgrounds, but they are more prevalent in people of Ashkenazi Jewish descent (approximately 1 in 40 carry a BRCA1 or BRCA2 founder mutation, compared to roughly 1 in 400 in the general population).

How Is a BRCA1 Mutation Inherited?

BRCA1 mutations follow an autosomal dominant inheritance pattern. This means:

β„Ή

Carrying a mutation β‰  having cancer

A positive BRCA1 result means you have an increased risk of developing cancer during your lifetime - it does not mean cancer is present now, or that cancer is inevitable. Many women with BRCA1 mutations live long, healthy lives with appropriate surveillance and, in some cases, preventive measures.

What Are the Cancer Risks?

BRCA1 mutations are associated with significantly elevated lifetime cancer risks compared to the general population. The estimates below reflect published ranges - individual risk varies based on family history, specific mutation type, and other factors.

General Population (No Mutation)

Breast cancer (lifetime)~13%
Ovarian cancer (lifetime)~1–2%
Pancreatic cancer~1%
Male breast cancer<0.1%

BRCA1 Mutation Carriers

Breast cancer (lifetime)55–72%
Ovarian cancer (lifetime)44–46%
Pancreatic cancerElevated
Male breast cancer~1–2%
⚠

BRCA1-associated breast cancers tend to have specific features

Breast cancers arising in BRCA1 mutation carriers are more likely to be triple-negative (ER-negative, PR-negative, HER2-negative), higher grade, and diagnosed at a younger age than sporadic breast cancers. This makes early detection through supplemental MRI especially important, as triple-negative tumors can grow quickly between annual mammograms.

Screening Recommendations for BRCA1 Carriers

Women with a known BRCA1 mutation should follow high-risk screening protocols recommended by the American College of Radiology (ACR) and the National Comprehensive Cancer Network (NCCN):

βœ“
Annual breast MRI starting between ages 25 and 30, or 10 years before the youngest first-degree relative's breast cancer diagnosis (whichever is earlier)
βœ“
Annual mammogram (with tomosynthesis if available) starting at age 30
βœ“
Clinical breast exam every 6–12 months starting at age 25
βœ“
Gynecologic surveillance for ovarian cancer, typically beginning at age 30–35 - discuss with a gynecologic oncologist
βœ“
Referral to a genetic counselor if not already completed - both to confirm the result and to plan family testing
βœ“
Discussion of risk-reducing options with a breast surgeon or oncologist, including chemoprevention and, in select cases, risk-reducing surgery
βœ“

Why MRI matters so much for BRCA1 carriers

Mammography alone can miss a significant proportion of BRCA1-associated cancers, particularly in younger women with dense breast tissue. Combined annual mammogram and MRI raises cancer detection sensitivity to 91–98%. For BRCA1 carriers, this combined approach is the standard of care - not an optional upgrade.

What to Do After a Positive BRCA1 Result

1
Don't panic - get informed

A positive result is significant, but it is not a diagnosis of cancer. Take time to understand what the result means before making any major decisions. The steps below can help you move forward deliberately and with a clear plan.

2
See a genetic counselor if you haven't already

A board-certified genetic counselor can explain the specific mutation found, clarify what it means for your risk, and guide family testing decisions. If testing was ordered by your primary care doctor or gynecologist without a prior counseling appointment, one is still worthwhile.

3
Establish care with a high-risk breast program

Many academic medical centers and large cancer centers have dedicated high-risk programs that coordinate breast imaging, gynecology, genetic counseling, and surgery in one setting. Ask your doctor for a referral if one is available near you.

4
Schedule your first high-risk screening appointment

If you are not already enrolled in high-risk screening, this is the time to start. You will need both annual mammogram and annual breast MRI. Your imaging center or breast program can determine the appropriate starting age for your situation.

5
Inform blood relatives so they can consider testing

First-degree relatives (parents, siblings, children) each have a 50% chance of carrying the same mutation. Sharing this information gives them the opportunity to be tested and, if positive, to begin appropriate screening before a cancer develops.

6
Discuss risk-reduction strategies with your team

Options include chemoprevention medications (such as tamoxifen or raloxifene), risk-reducing salpingo-oophorectomy (removal of the ovaries and fallopian tubes), and risk-reducing mastectomy. These are deeply personal decisions that require careful discussion with a multidisciplinary team - there is no single right answer for every woman.

πŸ”— For additional information on BRCA mutations, cancer risk estimates, and testing guidelines, see the NCI BRCA Fact Sheet from the National Cancer Institute.

Frequently Asked Questions

I tested positive for BRCA1. Does that mean I will definitely get breast cancer?

No. A BRCA1 mutation significantly raises your lifetime risk - estimated at 55–72% - but it does not guarantee that you will develop cancer. Many women with BRCA1 mutations never develop breast cancer, particularly those who follow high-risk screening protocols and make informed decisions about risk reduction with their medical team.

My mother had breast cancer but never had genetic testing. Should I get tested?

Yes, this is a strong reason to consider genetic testing, especially if your mother was diagnosed before age 50, had bilateral cancer, or also had ovarian cancer. Ideally, an affected family member is tested first - this gives the most informative result. However, if that is not possible, you can still be tested yourself. A genetic counselor can help you decide the best approach.

My father's side of the family has a history of breast cancer. Does that count?

Absolutely. BRCA1 mutations can be inherited from your father. If your father's mother, sister, or aunt had breast or ovarian cancer - or if a male relative was diagnosed with breast cancer - that family history is medically relevant and should be included in any risk assessment or genetic counseling session.

I have a BRCA1 mutation. Do I have to have a mastectomy?

No. Risk-reducing mastectomy is one option and does reduce breast cancer risk by approximately 90%, but it is not required and is entirely your choice. Many women with BRCA1 mutations choose intensive surveillance (annual mammogram plus MRI) instead, and some choose chemoprevention medications. These are personal decisions that should be made with full information and with input from a breast surgeon, oncologist, and genetic counselor.

I am BRCA1 positive and pregnant. What does this mean for screening?

Pregnancy adds complexity to breast cancer surveillance. Mammography is generally avoided during pregnancy, and gadolinium-contrast MRI (used for breast MRI) is also typically deferred during the first trimester. A breast imaging specialist or high-risk program familiar with pregnancy-related imaging can help you navigate an appropriate plan. Raise this with your care team as early as possible.

Are there protections against genetic discrimination?

In the United States, the Genetic Information Nondiscrimination Act (GINA) protects against discrimination by health insurers and employers based on genetic test results. However, GINA does not cover life insurance, disability insurance, or long-term care insurance. A genetic counselor can help you understand these protections before you decide to pursue testing.

Related Topics

Have a breast imaging report? A board-certified radiologist with extensive subspecialty experience in breast imaging reviews every explanation before it reaches you.

Get My Report Explained
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Cancer risk estimates are statistical ranges derived from population studies and may not reflect your individual risk. Always work with a qualified genetic counselor, physician, or breast specialist regarding your personal situation.